The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

Mount Sinai Hospital, New York

Emory University-Winship Cancer Institute, Atlanta

Ohio State University Comprehensive Cancer Center, Columbus

University of Michigan, Ann Arbor

Loyola University Medical Center, Maywood

Washington University School of Medicine, St Louis

City of Hope, Duarte

Oregon Health Sciences, Portland

Massachusetts General Hospital, Boston

Boston Children's Hospital, Boston

Dana-Farber Cancer Institute- Hematopoietic Stem Cell Transplant Program, Boston